These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20811714)

  • 1. Protective effect of the dopamine D(3) receptor agonist (7-OH-PIPAT) against apoptosis in malignant peripheral nerve sheath tumor (MPNST) cells.
    Castorina A; Giunta S; D'Agata V
    Int J Oncol; 2010 Oct; 37(4):927-34. PubMed ID: 20811714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP and VIP affect NF1 expression in rat malignant peripheral nerve sheath tumor (MPNST) cells.
    Giunta S; Castorina A; Adorno A; Mazzone V; Carnazza ML; D'Agata V
    Neuropeptides; 2010 Feb; 44(1):45-51. PubMed ID: 19919880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
    Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS.
    Reuss DE; Mucha J; Hagenlocher C; Ehemann V; Kluwe L; Mautner V; von Deimling A
    PLoS One; 2013; 8(2):e57152. PubMed ID: 23437333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAS/MEK-independent gene expression reveals BMP2-related malignant phenotypes in the Nf1-deficient MPNST.
    Sun D; Haddad R; Kraniak JM; Horne SD; Tainsky MA
    Mol Cancer Res; 2013 Jun; 11(6):616-27. PubMed ID: 23423222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet-derived growth factor-BB.
    Dang I; DeVries GH
    J Neurosci Res; 2005 Feb; 79(3):318-28. PubMed ID: 15602756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Pten expression in human malignant peripheral nerve sheath tumours.
    Bradtmöller M; Hartmann C; Zietsch J; Jäschke S; Mautner VF; Kurtz A; Park SJ; Baier M; Harder A; Reuss D; von Deimling A; Heppner FL; Holtkamp N
    PLoS One; 2012; 7(11):e47595. PubMed ID: 23139750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of somatostatin receptors in peripheral nerve sheath tumors.
    Mawrin C; Schulz S; Hellwig-Patyk A; Kirches E; Roessner A; Lendeckel U; Firsching R; Vorwerk CK; Keilhoff G; Dietzmann K; Grimm K; Lindberg G; Gutmann DH; Scheithauer BW; Perry A
    J Neuropathol Exp Neurol; 2005 Dec; 64(12):1080-8. PubMed ID: 16319718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.
    Byer SJ; Eckert JM; Brossier NM; Clodfelder-Miller BJ; Turk AN; Carroll AJ; Kappes JC; Zinn KR; Prasain JK; Carroll SL
    Neuro Oncol; 2011 Jan; 13(1):28-41. PubMed ID: 21075781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.
    Brossier NM; Prechtl AM; Longo JF; Barnes S; Wilson LS; Byer SJ; Brosius SN; Carroll SL
    J Neuropathol Exp Neurol; 2015 Jun; 74(6):568-86. PubMed ID: 25946318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms.
    Reuss DE; Habel A; Hagenlocher C; Mucha J; Ackermann U; Tessmer C; Meyer J; Capper D; Moldenhauer G; Mautner V; Frappart PO; Schittenhelm J; Hartmann C; Hagel C; Katenkamp K; Petersen I; Mechtersheimer G; von Deimling A
    Acta Neuropathol; 2014 Apr; 127(4):565-72. PubMed ID: 24464231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of malignant triton tumors.
    Strauss BL; Gutmann DH; Dehner LP; Hirbe A; Zhu X; Marley EF; Liapis H
    Hum Pathol; 1999 Aug; 30(8):984-8. PubMed ID: 10452514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.
    Wood M; Rawe M; Johansson G; Pang S; Soderquist RS; Patel AV; Nelson S; Seibel W; Ratner N; Sanchez Y
    Mol Cancer Ther; 2011 Sep; 10(9):1740-50. PubMed ID: 21697395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
    Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
    Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Gα12.
    Wang Z; Guan W; Han Y; Ren H; Tang X; Zhang H; Liu Y; Fu J; He D; Asico LD; Jose PA; Zhou L; Chen L; Zeng C
    Transplantation; 2015 Nov; 99(11):2274-84. PubMed ID: 25989500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Kit receptor expression in normal human Schwann cells and Schwann cell lines derived from neurofibromatosis type 1 tumors.
    Dang I; Nelson JK; DeVries GH
    J Neurosci Res; 2005 Nov; 82(4):465-71. PubMed ID: 16235251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.
    Yang K; Guo W; Ren T; Huang Y; Han Y; Zhang H; Zhang J
    J Exp Clin Cancer Res; 2019 May; 38(1):185. PubMed ID: 31053152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings.
    Spurlock G; Knight SJ; Thomas N; Kiehl TR; Guha A; Upadhyaya M
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1869-80. PubMed ID: 20229272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.